Review Article
Expectations about New Cancer Treatments
Robert Skopec
Correspondence Address :
Robert Skopec
Biologistresearcher
Dubnik, Slovakia, AXON
Europe
Email:
zxcbnvm7@gmail.com
Received on: September 14, 2017, Accepted on: September 30, 2017, Published on: October 13, 2017
Citation: Robert Skopec (2017). Expectations about New Cancer Treatments
Copyright: 2017 Robert Skopec. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
In 2015, Michael D. Becker, a former biotech executive, was diagnosed with head and neck cancer, which was caused by human papillomavirus (HPV), a sexually transmitted infection. Mr. Becker knows a lot about cancer and cancer drug development, used his expertise in the drug industry to consider possible treatment options. One he was enthusiastic about was the cancer immunotherapy. Unlike chemotherapy, which involves administering powerful drugs that kill both cancerous and healthy cells (most healthy cells can repair themselves), immunotherapy harness the power of the immune system to help it identify and knock out just the cancerous cells.
Keywords: Head and Neck Cancer, Chemotherapy, Immunotherapy, Human Papillomavirus, Checkpoint Inhibitor, the Medial Survival Rate, Cure